Evidence map›Paper›PMID 25974216›Full record

ArticleeLife2015

Mitochondrial Ca²⁺ and membrane potential, an alternative pathway for Interleukin 6 to regulate CD4 cell effector function.

Rui Yang, Dario Lirussi, Tina M Thornton, Dawn M Jelley-Gibbs, Sean A Diehl, Laure K Case, Muniswamy Madesh, Douglas J Taatjes, Cory Teuscher, Laura Haynes and 1 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 93 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. NovelImmune network · 2025
    Article
  6. MAM-STAT3-Driven Mitochondrial CaAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery.Journal of experimental & clinical cancer research : CR · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. STAT3 Role in T-Cell Memory Formation.International journal of molecular sciences · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Rui YangDepartment of Medicine, Immunobiology Program, University of Vermont, Burlington, United States.
Dario LirussiDepartment of Medicine, Immunobiology Program, University of Vermont, Burlington, United States.
Tina M ThorntonDepartment of Medicine, Immunobiology Program, University of Vermont, Burlington, United States.
Dawn M Jelley-GibbsTrudeau Institute, Saranac Lake, United States.
Sean A DiehlDepartment of Medicine, Immunobiology Program, University of Vermont, Burlington, United States.
Laure K CaseDepartment of Medicine, Immunobiology Program, University of Vermont, Burlington, United States.
Muniswamy MadeshDepartment of Medical Genetics and Molecular Biochemistry, Temple University, Philadelphia, United States.
Douglas J TaatjesDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, United States.
Cory TeuscherDepartment of Medicine, Immunobiology Program, University of Vermont, Burlington, United States.
Laura HaynesTrudeau Institute, Saranac Lake, United States.
Mercedes RincónDepartment of Medicine, Immunobiology Program, University of Vermont, Burlington, United States.
University of Vermont · USTrudeau Institute · USImaging Center · USTemple University · US

Funding

MOLECULAR BIOLOGY COREP01AG021600 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HAYNES, LAURA · 2003 to 2016
$24.4M
Vermont Immunobioloigy/ Infectious Diseases CenterP20GM103496 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2012 to 2015
$8.7M
Project 3 Dysregulation of metabolic communication of oligodendrocytes and neurons by cocaine and TatP01DA037830 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI KHALILI, KAMEL · 2015 to 2019
$7.4M
INVERTED LASER-SCANNING CONFOCAL MICROSCOPE: LUNG RESEARCHS10RR019246 · NCRR · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI TAATJES, DOUGLAS J. · 2004 to 2004
$473k
IL-6: an innate immune regulator for the plasticity of Tfh cellsR56AI094027 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI RINCON, MERCEDES · 2012 to 2012
$441k
NCRR NIH HHS RR019246-01NCRR NIH HHS S10 RR019246NIAID NIH HHS R56 AI094027NIAID NIH HHS R56AI094027NIA NIH HHS P01 AG021600NIDA NIH HHS P01 DA037830NIGMS NIH HHS P20 GM103496
6 · The paper itself

Abstract

IL-6 plays an important role in determining the fate of effector CD4 cells and the cytokines that these cells produce. Here we identify a novel molecular mechanism by which IL-6 regulates CD4 cell effector function. We show that IL-6-dependent signal facilitates the formation of mitochondrial respiratory chain supercomplexes to sustain high mitochondrial membrane potential late during activation of CD4 cells. Mitochondrial hyperpolarization caused by IL-6 is uncoupled from the production of ATP by oxidative phosphorylation. However, it is a mechanism to raise the levels of mitochondrial Ca(2+) late during activation of CD4 cells. Increased levels of mitochondrial Ca(2+) in the presence of IL-6 are used to prolong Il4 and Il21 expression in effector CD4 cells. Thus, the effect of IL-6 on mitochondrial membrane potential and mitochondrial Ca(2+) is an alternative pathway by which IL-6 regulates effector function of CD4 cells and it could contribute to the pathogenesis of inflammatory diseases.

Indexed as

AnimalsCalciumCalcium SignalingCD4-Positive T-LymphocytesInterleukin-21Interleukin-6InterleukinsMembrane PotentialsMiceMice, Inbred C57BLMice, KnockoutMitochondriaMitochondrial MembranesSignal TransductionVesicular Transport ProteinsCalciumInterleukin-21Interleukin-6InterleukinsTXLNA protein, mouseVesicular Transport Proteinscalciumeffector cytokinesIL-6immunologymitochondrionmouseNFATc2Stat3

Identifiers

PMID25974216
PMCPMC4447996
OpenAlexW2103638873

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.